COMMUNIQUÉS West-GlobeNewswire

Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing
29/05/2026
SINGAPORE, May 29, 2026 (GLOBE NEWSWIRE) -- Cuprina Holdings ( Cayman ) Limited ( Nasdaq: CUPR ) (“ Cuprina ” or “ the Company ”), a biomedical company developing and marketing products for the chronic wounds, [...]
Seer Files ITC Complaint Against Nanomics
29/05/2026
Seeks Exclusion Order Barring Importation of Infringing Proteonano Kits and Workstations REDWOOD CITY, Calif., May 29, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased [...]
PICARD MEDICAL, INC. Issues Letter to Shareholders
29/05/2026
TUCSON, Ariz., May 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the “Company” or “Picard Medical”), parent company of SynCardia Systems LLC, maker of the world’s first and only total [...]
Agios Provides Update on Phase 2b Trial of Tebapivat in Lower-Risk Myelodysplastic Syndromes
29/05/2026
Results did not meet predefined threshold to support further development in LR-MDS Tebapivat was well tolerated, with no new safety signals observed CAMBRIDGE, Mass., May 29, 2026 (GLOBE NEWSWIRE) -- Agios [...]
Spectral Medical Announces PMA Submission to U.S. FDA for PMX
29/05/2026
TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced the [...]
Mud Wtr Reviews: Is This Mushroom Coffee Alternative Worth Drinking?
29/05/2026
Mud Wtr Reviews: Is This Mushroom Coffee Alternative Washington dc, May 29, 2026 (GLOBE NEWSWIRE) -- Mud Wtr Reviews: Is This Mushroom Coffee Alternative Worth Drinking? If you have seen Mud Wtr ads everywhere and [...]
EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy
29/05/2026
EDAP Announces Corporate Name Change to FocalTherics ™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy Company will Begin Trading Under New Ticker Symbol “FOCL” at Market Open on June 1, 2026 Company [...]
Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical
29/05/2026
SAN DIEGO and TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“ Aptose ” or the “ Company ”) (TSX: APS; OTC: APTOF) announced today that closing of the previously announced arrangement (the “ [...]
At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research
29/05/2026
Over 30 scientific presentations leverage clonoSEQ MRD testing to assess novel therapies and support MRD-guided patient care across blood cancers SEATTLE, May 29, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies [...]
Glass House Brands Completes Previously Announced Warrant Redemption
29/05/2026
LONG BEACH, Calif. and TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the “Company”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF) today announced the [...]
Dr. Kamalesh Sets New Benchmarks for Urological Surgery in the UAE: Minimally Invasive, Maximum Results!
29/05/2026
DUBAI, United Arab Emirates, May 29, 2026 (GLOBE NEWSWIRE) -- Recognized as one of the best urologists in Dubai , Dr. Kamalesh is raising the standard for patient care as the UAE enters the hotter summer months, a [...]
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview
29/05/2026
New Taipei City, Taiwan, May 29, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization [...]
Replimune Announces Planned RP1 BLA Resubmission Following Productive Discussion with FDA
29/05/2026
WOBURN, Mass., May 29, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that following [...]
Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds
29/05/2026
BRISBANE, Calif., May 29, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (the “Company”), a clinical-stage biotechnology company developing a pipeline of advanced CAR-T cell therapy product [...]
Tenaya Therapeutics to Participate in the Jefferies Global Healthcare Conference 2026
29/05/2026
SOUTH SAN FRANCISCO, Calif., May 29, 2026 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative [...]
Rhythm Pharmaceuticals Announces Seven Abstracts Accepted for Presentation at ENDO 2026
29/05/2026
BOSTON, May 29, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]
PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026
29/05/2026
DELRAY BEACH, Fla., May 29, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the fourth quarter and fiscal [...]
Omniscient Secures USD 27.2M Series D to Accelerate Commercialization of AI-Enabled Brain Technology
29/05/2026
Funding to scale FDA-cleared Quicktome® platform and drive next-generation personalized brain care globally SAN FRANCISCO, May 29, 2026 (GLOBE NEWSWIRE) -- Omniscient (o8t®), a pioneer in AI-driven brain analysis [...]
SAB BIO to Present Data on SAB-142 at The American Diabetes Association’s 2026 Scientific Sessions and FOCIS 2026 Annual Meeting
29/05/2026
Data will highlight deeper mechanistic insights and long-term dosing potential of SAB-142, a fully human multi-specific ATG for newly diagnosed Stage 3 T1D MIAMI, May 29, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, [...]

Pages